Mathias Schmelcher1, Yang Shen2, Daniel C Nelson3, Marcel R Eugster4, Fritz Eichenseher4, Daniela C Hanke4, Martin J Loessner4, Shengli Dong5, David G Pritchard5, Jean C Lee6, Stephen C Becker7, Juli Foster-Frey7, David M Donovan7. 1. Animal Biosciences and Biotechnology Laboratory, ANRI, NEA, ARS, USDA, 10300 Baltimore Ave., Beltsville, MD 20705-2350, USA Institute of Food, Nutrition and Health, ETH Zurich, Schmelzbergstrasse 7, 8092 Zurich, Switzerland mathias.schmelcher@hest.ethz.ch. 2. Institute of Food, Nutrition and Health, ETH Zurich, Schmelzbergstrasse 7, 8092 Zurich, Switzerland Institute for Bioscience and Biotechnology Research, University of Maryland, 9600 Gudelsky Drive, Rockville, MD 20850, USA. 3. Institute for Bioscience and Biotechnology Research, University of Maryland, 9600 Gudelsky Drive, Rockville, MD 20850, USA Department of Veterinary Medicine, University of Maryland, 8075 Greenmead Drive, College Park, MD 20742, USA. 4. Institute of Food, Nutrition and Health, ETH Zurich, Schmelzbergstrasse 7, 8092 Zurich, Switzerland. 5. Department of Biochemistry and Molecular Genetics, MCLM 552, University of Alabama at Birmingham, 1530 3rd Ave., Birmingham, AL 35294-0005, USA. 6. Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. 7. Animal Biosciences and Biotechnology Laboratory, ANRI, NEA, ARS, USDA, 10300 Baltimore Ave., Beltsville, MD 20705-2350, USA.
Abstract
OBJECTIVES: In the light of increasing drug resistance in Staphylococcus aureus, bacteriophage endolysins [peptidoglycan hydrolases (PGHs)] have been suggested as promising antimicrobial agents. The aim of this study was to determine the antimicrobial activity of nine enzymes representing unique homology groups within a diverse class of staphylococcal PGHs. METHODS: PGHs were recombinantly expressed, purified and tested for staphylolytic activity in multiple in vitro assays (zymogram, turbidity reduction assay and plate lysis) and against a comprehensive set of strains (S. aureus and CoNS). PGH cut sites in the staphylococcal peptidoglycan were determined by biochemical assays (Park-Johnson and Ghuysen procedures) and MS analysis. The enzymes were tested for their ability to eradicate static S. aureus biofilms and compared for their efficacy against systemic MRSA infection in a mouse model. RESULTS: Despite similar modular architectures and unexpectedly conserved cleavage sites in the peptidoglycan (conferred by evolutionarily divergent catalytic domains), the enzymes displayed varying degrees of in vitro lytic activity against numerous staphylococcal strains, including cell surface mutants and drug-resistant strains, and proved effective against static biofilms. In a mouse model of systemic MRSA infection, six PGHs provided 100% protection from death, with animals being free of clinical signs at the end of the experiment. CONCLUSIONS: Our results corroborate the high potential of PGHs for treatment of S. aureus infections and reveal unique antimicrobial and biochemical properties of the different enzymes, suggesting a high diversity of potential applications despite highly conserved peptidoglycan target sites.
OBJECTIVES: In the light of increasing drug resistance in Staphylococcus aureus, bacteriophage endolysins [peptidoglycan hydrolases (PGHs)] have been suggested as promising antimicrobial agents. The aim of this study was to determine the antimicrobial activity of nine enzymes representing unique homology groups within a diverse class of staphylococcal PGHs. METHODS: PGHs were recombinantly expressed, purified and tested for staphylolytic activity in multiple in vitro assays (zymogram, turbidity reduction assay and plate lysis) and against a comprehensive set of strains (S. aureus and CoNS). PGH cut sites in the staphylococcal peptidoglycan were determined by biochemical assays (Park-Johnson and Ghuysen procedures) and MS analysis. The enzymes were tested for their ability to eradicate static S. aureus biofilms and compared for their efficacy against systemic MRSA infection in a mouse model. RESULTS: Despite similar modular architectures and unexpectedly conserved cleavage sites in the peptidoglycan (conferred by evolutionarily divergent catalytic domains), the enzymes displayed varying degrees of in vitro lytic activity against numerous staphylococcal strains, including cell surface mutants and drug-resistant strains, and proved effective against static biofilms. In a mouse model of systemic MRSA infection, six PGHs provided 100% protection from death, with animals being free of clinical signs at the end of the experiment. CONCLUSIONS: Our results corroborate the high potential of PGHs for treatment of S. aureus infections and reveal unique antimicrobial and biochemical properties of the different enzymes, suggesting a high diversity of potential applications despite highly conserved peptidoglycan target sites.
Authors: Biswajit Biswas; Sankar Adhya; Paul Washart; Brian Paul; Andrei N Trostel; Bradford Powell; Richard Carlton; Carl R Merril Journal: Infect Immun Date: 2002-01 Impact factor: 3.441
Authors: D E Kerr; K Plaut; A J Bramley; C M Williamson; A J Lax; K Moore; K D Wells; R J Wall Journal: Nat Biotechnol Date: 2001-01 Impact factor: 54.908
Authors: David M Donovan; Shengli Dong; Wes Garrett; Geneviève M Rousseau; Sylvain Moineau; David G Pritchard Journal: Appl Environ Microbiol Date: 2006-04 Impact factor: 4.792
Authors: Christopher Weidenmaier; John F Kokai-Kun; Sascha A Kristian; Tanya Chanturiya; Hubert Kalbacher; Matthias Gross; Graeme Nicholson; Birgid Neumeister; James J Mond; Andreas Peschel Journal: Nat Med Date: 2004-02-01 Impact factor: 53.440
Authors: Carolin T Verbree; Steven M Dätwyler; Susanne Meile; Fritz Eichenseher; David M Donovan; Martin J Loessner; Mathias Schmelcher Journal: Appl Environ Microbiol Date: 2017-03-17 Impact factor: 4.792
Authors: Ji Yun Bae; Kang Il Jun; Chang Kyung Kang; Kyoung-Ho Song; Pyoeng Gyun Choe; Ji-Hwan Bang; Eu Suk Kim; Sang Won Park; Hong Bin Kim; Nam-Joong Kim; Wan Beom Park; Myoung-Don Oh Journal: Antimicrob Agents Chemother Date: 2019-03-27 Impact factor: 5.191
Authors: Hyun Koo; Raymond N Allan; Robert P Howlin; Paul Stoodley; Luanne Hall-Stoodley Journal: Nat Rev Microbiol Date: 2017-09-25 Impact factor: 60.633
Authors: Carolin T Verbree; Steven M Dätwyler; Susanne Meile; Fritz Eichenseher; David M Donovan; Martin J Loessner; Mathias Schmelcher Journal: Appl Environ Microbiol Date: 2017-12-15 Impact factor: 4.792